Warning

Oral antibiotics, especially those with high oral bioavailability, can be used effectively to treat infections.

When to consider oral switch:

1. Is your patient improving?

Thing to consider:

  • patient clinically improving
  • NEWS2 stable or falling
  • infection markers (e.g. temperature, WCC) stable or falling.

 

2. Does your patient have an oral/enteral route?

Things to consider:

  • patient eating/drinking/NG in place
  • no GI issues (malabsorption/vomiting)
  • patient compliance with orals

 

3. Are there supportive infection diagnostic results?

Can oral regimes be guided by positive microbiology samples/other relevant diagnostics?

For some bug-drug combinations high dose oral regimes may be required.

 

4. Is there a complicated/deep-seated infection?

These infections are not necessarily a contraindication to oral regimes, indeed it’s becoming more common for oral regimes to be used. Please discuss with microbiology/infection specialist.

 

5. Can I make an empirical oral switch?

For common infections there are empirical oral switch antibiotics and empirical durations.

Common IVOS regimes can be found throughout our guidance and are summarised below:

 

Indication

Total duration

(IV + oral$)

Empiric Oral Switch
1st Line 2nd Line/ Penicillin allergy/ Previous MRSA

Sepsis of unknown source

5 days

Co-trimoxazole 960mg every 12 hours

(IF intra-abdominal source likely ADD Metronidazole 400mg every 8 hours) 

Co-trimoxazole 960mg every 12 hours

(IF intra-abdominal source likely ADD Metronidazole 400mg every 8 hours) 

Skin and Soft Tissue Infections
Cellulitis 5 days Flucloxacillin 1g every 6 hours

Doxycycline 100mg every 12 hours

OR

Clarithromycin 500mg every 12 hours

Diabetic foot infection (mild) 7 days Flucloxacillin 1g every 6 hours

Doxycycline 100mg every 12 hours

OR

Co-trimoxazole 960mg every 12 hours

Diabetic foot infection (moderate) 7 days

Flucloxacillin 1g every 6 hours AND

Metronidazole 400mg every 8 hours

Co-trimoxazole every 12 hours AND

Metronidazole 400mg every 8 hours

Human/Animal Bite Infection 5 days Co-amoxiclav* 625mg every 8 hours

Doxycycline 100mg every 12 hours AND

Metronidazole 400mg every 8 hours

Respiratory Infections
Community Acquired Pneumonia (CURB 0-2) 5 days Amoxicillin+ 500mg-1g every 8 hours Doxycycline 200mg on first day then 100mg daily
Community Acquired Pneumonia (CURB 3-5) Co-amoxiclav*+ 625mg every 8 hours Doxycycline 200mg on first day then 100mg daily
Aspiration Pneumonia (low severity) Amoxicillin 1g every 8 hours

Co-trimoxazole 960mg every 12 hours

OR

Doxycycline 200mg on first day then 100mg daily

Aspiration Pneumonia (high severity)

Amoxicillin 1g every 8 hours AND

Metronidazole 400mg every 8 hours

Co-trimoxazole 960mg every 12 hours AND

Metronidazole 400mg every 8 hours

OR

Doxycycline 200mg on first day then 100mg daily AND

Metronidazole 400mg every 8 hours

Hospital-acquired Pneumonia (late onset) Doxycycline 200mg on first day then 100mg daily Co-trimoxazole 960mg every 12 hours
Urinary tract Infections
Pyelonephritis/ Urosepsis/ Upper Urinary Tract Infection 7 days

Co-trimoxazole 960mg every 12 hours

OR

Co-amoxiclav* 625mg every 8 hours

Co-trimoxazole 960mg every 12 hours
Intra-abdominal Infections
Biliary tract infection/ Appendicitis/ Diverticulitis

5 days

(after adequate source control)

Co-trimoxazole 960mg every 12 hours AND

Metronidazole 400mg every 8 hours

OR

Co-amoxiclav* 625mg every 8 hours

Co-trimoxazole 960mg every 12 hours AND

Metronidazole 400mg every 8 hours

Spontaneous bacterial peritonitis 5 days

Co-trimoxazole 960mg every 12 hours

OR

Co-amoxiclav* 625mg every 8 hours

Co-trimoxazole 960mg every 12 hours

*Suitable for those ≤ 65 years old with a low risk of C.diff infection (CDI). See risk factors for CDI.

+ For CAP consider if atypical cover required (patient has risk factors or compatible clinical features), see atypical pneumonia.

Please remember to add stop dates for prescriptions e.g. in HEPMA.

Editorial Information

Last reviewed: 01/11/2024

Next review date: 01/11/2027